Craig A. Waldman

Craig Waldman, who co-chairs Jones Day's global Antitrust Practice, has more than 20 years of experience representing companies in antitrust government investigations, private litigations, and by counseling them on how to manage antitrust risk in daily business activities. Craig's work has included all areas of antitrust including mergers, agreements among competitors, vertical distribution issues, price discrimination, criminal antitrust matters, monopolization, and intellectual property licensing and trade regulation.

He has worked across many industries, including IT hardware and software, networking, electronic design automation, electronic platforms, health care, consumer products, credit cards, financial institutions, medical devices, defense, sports, financial markets, life sciences, oil and gas, retail stores, satellites, telecommunications, tobacco, and transportation. The companies Craig represents include Dignity Health, Lam Research, NVIDIA, Reynolds, SAP, Synopsys, and Wabtec.

From 1993 to 1996, Craig served as an attorney in the Federal Trade Commission's Mergers I division during which time he was involved in high-profile investigations including Rite Aid's attempted acquisition of Revco, Lockheed's purchase of Martin Marietta, First Financial's merger with First Data, and Glaxo's acquisition of Wellcome, among others.

Craig is a frequent speaker on all antitrust issues. He has served as an adjunct professor at both Berkeley and Hastings Law Schools, has lectured at Stanford Business School, and has served in numerous roles within ABA Antitrust Leadership.

For over 10 years, he has served on the board of directors of Global Strategies, an international charity whose mission is to reduce early mortality and treat survivors of sexual violence in impoverished and war torn regions of Africa.